Double trouble: myocardial infarction with non-obstructive coronary arteries as a presentation of Hughes syndrome in monozygotic twins

Abstract

Myocardial infarction with non-obstructive coronary arteries (MINOCA) is a recently described, clinically significant entity, with prevalence rates ranging from 1% to 14% and a mean of 6% of all patients with myocardial infarction. Antiphospholipid syndrome (APS; Hughes syndrome) is characterized by the presence of antiphospholipid antibodies associated with thrombosis (arterial and/or venous) and/or pregnancy morbidity and could be the cause of MINOCA. Data on genetic predisposition to APS are scarce. The present study describes a unique case of monozygotic twin brothers who, at a young age, developed the same clinical presentation of APS. The diagnosis of APS was later confirmed, along with a diagnosis of systemic lupus erythematosus in one brother.

Keywords

Antiphospholipid syndrome systemic lupus erythematosus MINOCA

Get full access to this article

View all access options for this article.

References

Khamashta

Taraborelli

Sciascia

Tincani

. Antiphospholipid syndrome. Best Pract Res Clin Rheumatol 2016; 30: 133–148.

Stojanovich

Djokovic

. Tomography and blood vessels in Hughes syndrome. Lupus 2014; 23: 337–341.

Stojanovich

Kontic

Smiljanic

Djokovic

Stamenkovic

Marisavljevic

. Association between non-thrombotic neurological and cardiac manifestations in patients with antiphospholipid syndrome. Clin Exp Rheumatol 2013; 31: 756–760.

Sebastiani

Iuliano

Cantarini

Galeazzi

. Genetic aspects of the antiphospholipid syndrome: an update. Autoimmunity Rev 2016; 15: 433–439.

Pasupathy

Air

Dreyer

Tavella

Beltrame

. Systematic review of patients presenting with suspected myocardial infarction and nonobstructive coronary arteries. Circulation 2015; 131: 861–870.

Pengo

Tripodi

Reber

, et al. Update of the guidelines for lupus anticoagulant detection. Subcommittee on Lupus Anticoagulant/Antiphospholipid Antibody of the Scientific and Standardisation Committee of the International Society on Thrombosis and Haemostasis. J Thromb Haemost 2009; 7: 1737–1740.

Miyakis

Lockshin

Atsumi

, et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost 2006; 4: 295–306.

Hochberg

. Updating the American College of Rheumatology revised criteria for the classiﬁcation of systemic lupus erythematosus. Arthritis Rheum 1997; 40: 1725–1725.

Exner

Barber

Kronenberg

Rickard

. Familial association of the lupus anticoagulant. Br J Haematol 1980; 45: 89–96.

10.

Ravindran

Rajendran

Elias

. Primary antiphospholipid syndrome in monozygotic twins. Lupus 2013; 22: 92–94.

11.

Thygesen

Alpert

Jaffe

, et al. ESC Scientific Document Group. Fourth universal definition of myocardial infarction (2018). Eur Heart J 2019; 40: 237–269.

12.

Safdar

Spatz

Dreyer

, et al. Clinical profile, and prognosis of young patients with myocardial infarction with nonobstructive coronary arteries (MINOCA): results from the VIRGO Study. J Am Heart Assoc 2018; 7.